KK
MYGN icon

KLP Kapitalforvaltning’s Myriad Genetics MYGN Stock Holding History

KLP Kapitalforvaltning’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-19,900
Closed -$89.5K – 2183
2026
Q1 		$89.5K Hold
19,900
– – ﹤0.01% 2074
2025
Q4 		$122K Buy
19,900
+1,900
+11% +$13.8K ﹤0.01% 2014
2025
Q3 		$130K Hold
18,000
– – ﹤0.01% 1988
2025
Q2 		$95.6K Hold
18,000
– – ﹤0.01% 2052
2025
Q1 		$160K Hold
18,000
– – ﹤0.01% 1842
2024
Q4 		$247K Buy
+18,000
New +$332K ﹤0.01% 1734

Other funds holding MYGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

KLP Kapitalforvaltning's MYGN Position: Q2 2026 in Review

KLP Kapitalforvaltning sold out of Myriad Genetics (MYGN) in Q2 2026, closing a stake of 19,900 shares — an estimated $89.5K sold.

KLP Kapitalforvaltning first reported a position in MYGN in Q4 2024 and held it in 6 quarters. The position peaked at $247K in Q4 2024. 197 funds tracked by Wall St. Rank hold MYGN as of Q2 2026.

  • KLP Kapitalforvaltning reported no remaining Myriad Genetics position as of Q2 2026 after selling out during the quarter.
  • KLP Kapitalforvaltning sold 19,900 Myriad Genetics shares in Q2 2026, an estimated $89.5K.
  • KLP Kapitalforvaltning first reported a position in Myriad Genetics in Q4 2024 and held it in 6 quarters.
  • KLP Kapitalforvaltning's Myriad Genetics position peaked at $247K in Q4 2024.
  • 197 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.